These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18697235)

  • 1. What can I do to lower my lipoprotein(a) level?
    Heart Advis; 2008 Apr; 11(4):8. PubMed ID: 18697235
    [No Abstract]   [Full Text] [Related]  

  • 2. Niacin after coronary bypass grafting and for coronary disease prevention.
    Parsons WB
    Circulation; 2001 Jul; 104(2):E7. PubMed ID: 11447097
    [No Abstract]   [Full Text] [Related]  

  • 3. Antioxidants blunt high-density lipoprotein response to statin plus niacin therapy.
    Kris-Etherton PM
    Curr Atheroscler Rep; 2001 Nov; 3(6):435-6. PubMed ID: 11602062
    [No Abstract]   [Full Text] [Related]  

  • 4. Dramatic lowering of very high Lp(a) in response to niacin.
    Li M; Saeedi R; Rabkin SW; Frohlich J
    J Clin Lipidol; 2014; 8(4):448-50. PubMed ID: 25110227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of simvastatin-niacin and antioxidant therapy on HDL.
    Drown DJ
    Prog Cardiovasc Nurs; 2002; 17(2):102-3. PubMed ID: 11986546
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary: A new approach to atherogenic dyslipidemia.
    Reasner CA
    Postgrad Med; 2005 Apr; 117(4):13-6. PubMed ID: 15842128
    [No Abstract]   [Full Text] [Related]  

  • 7. Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.
    Scanu AM; Bamba R
    Am J Cardiol; 2008 Apr; 101(8A):44B-47B. PubMed ID: 18375241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin as a component of combination therapy for dyslipidemia.
    Miller M
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance in niacin response in individuals with elevated lipoprotein(a).
    Safarova MS; Ezhov MV
    J Clin Lipidol; 2014; 8(6):646-647. PubMed ID: 25499949
    [No Abstract]   [Full Text] [Related]  

  • 10. [What is the future for niacin after the AIM-HIGH study?].
    Cybulska B; Kłosiewicz Latoszek L
    Kardiol Pol; 2012; 70(3):315-6. PubMed ID: 22430425
    [No Abstract]   [Full Text] [Related]  

  • 11. The facts behind niacin.
    Hochholzer W; Berg DD; Giugliano RP
    Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply: To PMID 25110227.
    Saeedi R; Li M; Rankin S; Frohlich J
    J Clin Lipidol; 2014; 8(6):647. PubMed ID: 25499950
    [No Abstract]   [Full Text] [Related]  

  • 14. A case for immediate-release niacin.
    Bassan M
    Heart Lung; 2012; 41(1):95-8. PubMed ID: 21414665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
    Ahmed MH
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search and rescue for hypotheses surviving AIM-HIGH, the niacin therapy earthquake: still problematic after the primary publication.
    Brinton EA
    J Clin Lipidol; 2012; 6(4):312-7. PubMed ID: 22836067
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic role of niacin in dyslipidemia management.
    Boden WE; Sidhu MS; Toth PP
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):141-58. PubMed ID: 24363242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease.
    Kauffman AB; Olson KL; Youngblood ML; Zadvorny EB; Delate T; Merenich JA;
    J Clin Lipidol; 2010; 4(3):173-80. PubMed ID: 21122649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of niacin on atherosclerotic cardiovascular disease.
    Guyton JR
    Am J Cardiol; 1998 Dec; 82(12A):18U-23U; discussion 39U-41U. PubMed ID: 9915658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.